copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - agenți antineoplazici - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
amlessa comprimate 8 mg + 5 mg
krka d.d., novo mesto - perindoprilum terț-butilaminum + amlodipinum - comprimate - 8 mg + 5 mg
amlessa comprimate 4 mg + 10 mg
krka d.d., novo mesto - perindoprilum terț-butilaminum + amlodipinum - comprimate - 4 mg + 10 mg
amlessa comprimate 4 mg + 5 mg
krka d.d., novo mesto - perindoprilum terț-butilaminum + amlodipinum - comprimate - 4 mg + 5 mg
amlessa comprimate 8 mg + 10 mg
krka d.d., novo mesto - perindoprilum terț-butilaminum + amlodipinum - comprimate - 8 mg + 10 mg
r-cin 300 mg capsule
lupin limited - rifampicinum - capsule - 300 mg
rifampicin capsule 150 mg
centrul stiintific de producere "uzina chimico-farmaceutica borsceagov" sai - rifampicinum - capsule - 150 mg
diroton plus 20 mg/1,5 mg capsule cu eliberare modificată
gedeon richter plc - lisinoprilum + indapamidum - capsule cu eliberare modificată - 20 mg/1,5 mg
diroton plus 10 mg/1,5 mg capsule cu eliberare modificată
gedeon richter plc - lisinoprilum + indapamidum - capsule cu eliberare modificată - 10 mg/1,5 mg
diroton plus 5 mg/1,5 mg capsule cu eliberare modificată
gedeon richter plc - lisinoprilum + indapamidum - capsule cu eliberare modificată - 5 mg/1,5 mg